ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank36
5Y CAGR-8.5%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
-8.5%/yr
Long-term compound
Percentile
P36
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 12.38% |
| 2024 | 21.36% |
| 2023 | 9.04% |
| 2022 | -6.80% |
| 2021 | 1.90% |
| 2020 | 19.35% |
| 2019 | 22.53% |
| 2018 | 4.19% |
| 2017 | 36.79% |
| 2016 | 105.34% |